156 related articles for article (PubMed ID: 9365135)
1. Presence of two signaling TGF-beta receptors in human pancreatic cancer correlates with advanced tumor stage.
Lu Z; Friess H; Graber HU; Guo X; Schilling M; Zimmermann A; Korc M; Büchler MW
Dig Dis Sci; 1997 Oct; 42(10):2054-63. PubMed ID: 9365135
[TBL] [Abstract][Full Text] [Related]
2. Connective tissue growth factor is a regulator for fibrosis in human chronic pancreatitis.
di Mola FF; Friess H; Martignoni ME; Di Sebastiano P; Zimmermann A; Innocenti P; Graber H; Gold LI; Korc M; Büchler MW
Ann Surg; 1999 Jul; 230(1):63-71. PubMed ID: 10400038
[TBL] [Abstract][Full Text] [Related]
3. Connective tissue growth factor gene expression alters tumor progression in esophageal cancer.
Koliopanos A; Friess H; di Mola FF; Tang WH; Kubulus D; Brigstock D; Zimmermann A; Büchler MW
World J Surg; 2002 Apr; 26(4):420-7. PubMed ID: 11910473
[TBL] [Abstract][Full Text] [Related]
4. Transforming growth factor betas and their signaling receptors in human hepatocellular carcinoma.
Abou-Shady M; Baer HU; Friess H; Berberat P; Zimmermann A; Graber H; Gold LI; Korc M; Büchler MW
Am J Surg; 1999 Mar; 177(3):209-15. PubMed ID: 10219856
[TBL] [Abstract][Full Text] [Related]
5. Transforming growth factor-betas and their signaling receptors are coexpressed in Crohn's disease.
di Mola FF; Friess H; Scheuren A; Di Sebastiano P; Graber H; Egger B; Zimmermann A; Korc M; Büchler MW
Ann Surg; 1999 Jan; 229(1):67-75. PubMed ID: 9923802
[TBL] [Abstract][Full Text] [Related]
6. Attenuated ALK5 receptor expression in human pancreatic cancer: correlation with resistance to growth inhibition.
Baldwin RL; Friess H; Yokoyama M; Lopez ME; Kobrin MS; Büchler MW; Korc M
Int J Cancer; 1996 Jul; 67(2):283-8. PubMed ID: 8760600
[TBL] [Abstract][Full Text] [Related]
7. [Detection of the expression of Smad4, transforming growth factor beta(1) and beta receptor II proteins in paraffin-embedded human pancreatic cancer tissues].
Gu L; Chen J; Liu T; Li L; Lu Z; Luo Y
Zhonghua Bing Li Xue Za Zhi; 2001 Dec; 30(6):439-42. PubMed ID: 11866987
[TBL] [Abstract][Full Text] [Related]
8. Dissecting the role of TGF-beta type I receptor/ALK5 in pancreatic ductal adenocarcinoma: Smad activation is crucial for both the tumor suppressive and prometastatic function.
Schniewind B; Groth S; Sebens Müerköster S; Sipos B; Schäfer H; Kalthoff H; Fändrich F; Ungefroren H
Oncogene; 2007 Jul; 26(33):4850-62. PubMed ID: 17297450
[TBL] [Abstract][Full Text] [Related]
9. Altered expression of transforming growth factor-beta ligands and receptors in primary and recurrent ovarian carcinoma.
Bristow RE; Baldwin RL; Yamada SD; Korc M; Karlan BY
Cancer; 1999 Feb; 85(3):658-68. PubMed ID: 10091739
[TBL] [Abstract][Full Text] [Related]
10. Enhanced expression of the type II transforming growth factor beta receptor in human pancreatic cancer cells without alteration of type III receptor expression.
Friess H; Yamanaka Y; Büchler M; Berger HG; Kobrin MS; Baldwin RL; Korc M
Cancer Res; 1993 Jun; 53(12):2704-7. PubMed ID: 8389240
[TBL] [Abstract][Full Text] [Related]
11. Targeting endogenous transforming growth factor beta receptor signaling in SMAD4-deficient human pancreatic carcinoma cells inhibits their invasive phenotype1.
Subramanian G; Schwarz RE; Higgins L; McEnroe G; Chakravarty S; Dugar S; Reiss M
Cancer Res; 2004 Aug; 64(15):5200-11. PubMed ID: 15289325
[TBL] [Abstract][Full Text] [Related]
12. Enhanced expression of transforming growth factor beta isoforms in pancreatic cancer correlates with decreased survival.
Friess H; Yamanaka Y; Büchler M; Ebert M; Beger HG; Gold LI; Korc M
Gastroenterology; 1993 Dec; 105(6):1846-56. PubMed ID: 8253361
[TBL] [Abstract][Full Text] [Related]
13. Transforming growth factor betas and their receptors in human liver cirrhosis.
Baer HU; Friess H; Abou-Shady M; Berberat P; Zimmermann A; Gold LI; Korc M; Büchler MW
Eur J Gastroenterol Hepatol; 1998 Dec; 10(12):1031-9. PubMed ID: 9895050
[TBL] [Abstract][Full Text] [Related]
14. Expression of transforming growth factor beta1 and its type II receptor in mouse colon tumors induced by azoxymethane.
Wang QS; Guda K; Papanikolaou A; Dong M; Rosenberg DW
Int J Oncol; 2000 Sep; 17(3):551-8. PubMed ID: 10938397
[TBL] [Abstract][Full Text] [Related]
15. Overexpression of acidic and basic fibroblast growth factors in human pancreatic cancer correlates with advanced tumor stage.
Yamanaka Y; Friess H; Buchler M; Beger HG; Uchida E; Onda M; Kobrin MS; Korc M
Cancer Res; 1993 Nov; 53(21):5289-96. PubMed ID: 7693336
[TBL] [Abstract][Full Text] [Related]
16. Transforming growth factor-beta type II receptors and smad proteins in follicular thyroid tumors.
West J; Munoz-Antonia T; Johnson JG; Klotch D; Muro-Cacho CA
Laryngoscope; 2000 Aug; 110(8):1323-7. PubMed ID: 10942134
[TBL] [Abstract][Full Text] [Related]
17. Lack of expression of transforming growth factor-beta type II receptor associated with malignant progression in human salivary gland cell clones.
Azuma M; Yuki T; Tamatani T; Motegi K; Yoshida H; Sato M
Int J Cancer; 1996 Jun; 66(6):802-5. PubMed ID: 8647653
[TBL] [Abstract][Full Text] [Related]
18. Negative control of TRAIL-R1 signaling by transforming growth factor β1 in pancreatic tumor cells involves Smad-dependent down regulation of TRAIL-R1.
Radke DI; Ungefroren H; Helm O; Voigt S; Alp G; Braun H; Hübner S; Dilchert J; Sebens S; Adam D; Kalthoff H; Trauzold A
Cell Signal; 2016 Nov; 28(11):1652-62. PubMed ID: 27492861
[TBL] [Abstract][Full Text] [Related]
19. Enhanced expression of TGF-betas and their receptors in human acute pancreatitis.
Friess H; Lu Z; Riesle E; Uhl W; Bründler AM; Horvath L; Gold LI; Korc M; Büchler MW
Ann Surg; 1998 Jan; 227(1):95-104. PubMed ID: 9445116
[TBL] [Abstract][Full Text] [Related]
20. Bone morphogenetic protein 2 exerts diverse effects on cell growth in vitro and is expressed in human pancreatic cancer in vivo.
Kleeff J; Maruyama H; Ishiwata T; Sawhney H; Friess H; Büchler MW; Korc M
Gastroenterology; 1999 May; 116(5):1202-16. PubMed ID: 10220513
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
